MARKET NEWS

Oramed Reports Positive Results in the Final Cohort of its Phase 2b Oral Insulin Trial 
TrakCel & Ori Biotech Sign Collaboration Agreement 
Theralase Advances Its Pivotal Phase 2 Non-Muscle Invasive Bladder Cancer Study
Spring Bank Announces New Clinical Collaboration With Roche
Perrigo & Catalent Announce FDA Approval
FDA Grants IND Approval to Promising Anti-Cancer Agent

  FEATURED EDITORIAL

  COMPANY PROFILE

 

ILC Dover is a world-leader in the innovative design and production of engineered flexible protective solutions, for pharmaceutical and biopharmaceutical, flood protection, personal protection, bulk packaging, and aerospace industries. Our customers will attest to our relentless dedication to high value products, advanced technology, and responsive service, as our visionary solutions have improved efficiency while safeguarding people, product, and infrastructure in hazardous conditions since 1947. Click here for more.

Looking for an experienced and committed steriles CDMO? Look no further than Pii. Pii has a strong pedigree of scientific know-how and regulatory experience across a range of dosage forms, including capacity for aseptic fill-finish. Our commitment to this market and our capabilities have grown further with investment in a new, fully-robotic aseptic filling line. With expanded capacity for small to medium-batch production of commercial and clinical materials, we are eager to discuss your needs, so we can help advance your sterile product. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Pii Expands Aseptic Filling Capabilities With Fully Robotic Filling Line

Pii Expands Aseptic Filling Capabilities With Fully Robotic Filling Line

Pharmaceutics International, Inc. (Pii), a pharmaceutical contract development and manufacturing organization (CDMO), recently announced the expansion of its aseptic filling capacity and….

Novavax Advances Development of Novel COVID-19 Vaccine

Novavax Advances Development of Novel COVID-19 Vaccine

Novavax, Inc. recently announced progress in its efforts to develop a novel vaccine to protect against coronavirus disease COVID-19….

Arecor Achieves Second License Milestone Payment From Global Pharmaceutical Partner

Arecor Achieves Second License Milestone Payment From Global Pharmaceutical Partner

Arecor Ltd recently announced it has achieved an important second, contractual milestone with one of its pharmaceutical partners….

Alimera Sciences Meets Revenue Milestone & Accesses Additional .5 Million

Alimera Sciences Meets Revenue Milestone & Accesses Additional $2.5 Million

Alimera Sciences, Inc. recently announced it has drawn down the remaining $2.5 million under the $45-million term loan agreement with its current lenders, investment affiliates managed by…..

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

March 11 – Particle Design Technology
March 22 – Drug Delivery